Systemic inflammation, genetic susceptibility and lung function

Sunyer, J., Pistelli, R., Plana, E., Andreani, M., Baldari, F., Kolz, M., Koenig, W., Pekkanen, J., Peters, A., Forastiere, F.

Source: Eur Respir J 2008; 32: 92-97
Journal Issue: July
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sunyer, J., Pistelli, R., Plana, E., Andreani, M., Baldari, F., Kolz, M., Koenig, W., Pekkanen, J., Peters, A., Forastiere, F.. Systemic inflammation, genetic susceptibility and lung function. Eur Respir J 2008; 32: 92-97

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009



The polymorphisms of C-reactive protein gene modify the association between central obesity, asthma and lung function in Taiwan
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011

Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles
Source: Eur Respir J 2004; 24 : 798-804
Year: 2004



Airflow limitation, lung volumes and systemic inflammation in a general population
Source: Eur Respir J 2012; 39: 29-37
Year: 2012



Airflow limitation, lung volumes and systemic inflammation in a general population
Source: Eur Respir J 2011; 39: 29-37
Year: 2012



The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

Relationships between inflammatory markers, response to therapy, and lung function decline
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017


Blood levels of TNF-α, IFN-γ, IL-10, TGF-β1 and lung functional parameters in patients with advanced and earlier lung sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Genetic determinants of C-reactive protein in COPD
Source: Eur Respir J 2006; 28: 1156-1162
Year: 2006



Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study
Source: Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020
Year: 2022



Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Strain dependence of lung tissue mechanics in a murine model of chronic asthma
Source: Annual Congress 2006 - Respiratory mechanics
Year: 2006


Genetic influences on lung function decline in AATD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015

Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005


Homeobox-genes (HOX) in human lung - altered expression in lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001